Does the pharmacy expenditure of patients always correspond with their morbidity burden? Exploring new approaches in the interpretation of pharmacy expenditure.
BACKGROUND
The computerisation of primary health care (PHC) records offers the opportunity to focus on pharmacy expenditure from the perspective of the morbidity of individuals. The objective of the present study was to analyse the behaviour of pharmacy expenditure within different morbidity groups. We paid special attention to the identification of individuals who had higher values of pharmacy expenditure than their morbidity would otherwise suggest (i.e. outliers).


METHODS
Observational study consisting of 75,574 patients seen at PHC centres in Zaragoza, Spain, at least once in 2005. Demographic and disease variables were analysed (ACG 8.1), together with a response variable that we termed 'total pharmacy expenditure per patient'. Outlier patients were identified based on boxplot methods, adjusted boxplot for asymmetric distributions, and by analysing standardised residuals of tobit regression models.


RESULTS
The pharmacy expenditure of up to 7% of attendees in the studied PHC centres during one year exceeded expectations given their morbidity burden. This group of patients was responsible for up to 24% of the total annual pharmacy expenditure. There was a significantly higher number of outlier patients within the low-morbidity band which matched up with the higher variation coefficient observed in this group (3.2 vs. 2.0 and 1.3 in the moderate- and high-morbidity bands, respectively).


CONCLUSIONS
With appropriate validation, the methodologies of the present study could be incorporated in the routine monitoring of the prescribing profile of general practitioners. This could not only enable evaluation of their performance, but also target groups of outlier patients and foster analyses of the causes of unusually high pharmacy expenditures among them. This interpretation of pharmacy expenditure gives new clues for the efficiency in utilisation of healthcare resources, and could be complementary to management interventions focused on individuals with a high morbidity burden.
Calderón-Larrañaga
Amaia
A
Aragon Health Sciences Institute (I + CS), Zaragoza, Spain. acalderon.iacs@aragon.es
Poblador-Plou
Beatriz
B
López-Cabañas
Anselmo
A
Alcalá-Nalvaiz
José Tomás
JT
Abad-Díez
José María
JM
Bordonaba-Bosque
Daniel
D
Prados-Torres
Alexandra
A
D000328:Adult; D017281:Cost of Illness; D003953:Diagnosis-Related Groups / Q000191:economics / Q000706:statistics & numerical data; D011307:Drug Prescriptions / Q000191:economics*; D005260:Female; D005102:Health Expenditures / Q000706:statistics & numerical data*; D006801:Humans; D008297:Male; D016347:Medical Records Systems, Computerized; D008875:Middle Aged; D009017:Morbidity / Q000639:trends*; D011320:Primary Health Care / Q000191:economics / Q000458:organization & administration; D036301:Qualitative Research; D012189:Retrospective Studies; D012959:Socioeconomic Factors; D013030:Spain
Ann Fam Med. 2006 Mar-Apr;4(2):101-3
16569711
Health Care Manag Sci. 2003 Feb;6(1):27-35
12638924
Gerontologist. 2007 Oct;47(5):697-704
17989412
BMC Med. 2010 Jan 18;8:7
20082689
Health Educ Behav. 2009 Jun;36(3):505-17
18292218
Aten Primaria. 2002 Feb 15;29(2):84-9
11844424
Gac Sanit. 2001 Nov-Dec;15(6):513-8
11858786
Med Care. 2010 Feb;48(2):175-82
19927013
J Ambul Care Manage. 1994 Jan;17(1):29-38
10131098
Health Policy. 2006 Mar;76(1):13-25
15921818
Health Serv Res. 1991 Apr;26(1):53-74
1901841
J Health Care Finance. 2006 Spring;32(3):8-19
18975728
Aten Primaria. 1996 Jan;17(1):76-82
8742149
BMC Public Health. 2006 Feb 16;6:36
16483369
Med Care. 1991 May;29(5):452-72
1902278
Health Stat Q. 2004 Spring;(21):5-14
15615148
Med Care. 2003 Nov;41(11):1301-12
14583693
BMC Public Health. 2009 Sep 18;9:347
19765286
Fam Pract. 2000 Feb;17(1):36-41
10673486
Ann Pharmacother. 2008 Mar;42(3):368-74
18272699
Cochrane Database Syst Rev. 2008 Jul 16;(3):CD004398
18646106
Gac Sanit. 2009 May-Jun;23(3):228-31
19268402
Med Care. 2005 Jan;43(1):61-7
15626935
Soc Sci Med. 2005 Mar;60(6):1335-46
15626528
Aten Primaria. 2004 Sep 15;34(4):178-85
15388065
Pharmacoeconomics. 2003;21(2):89-103
12515571